We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,892

Pelman v. McDonald’s Corp.: no class certification for obese teens
  • Shook Hardy & Bacon LLP
  • USA
  • October 29 2010

A judge from the U.S. Court of International Trade, sitting by designation in a New York federal district court, has determined that the obesity-related claims filed in 2002 against McDonald’s Corp. cannot be pursued as a class action


Hospital walks back study linking aspartame to leukemia
  • Shook Hardy & Bacon LLP
  • USA
  • October 26 2012

Brigham and Women’s Hospital (BWM) has reportedly walked back a recent study claiming to link aspartame with an increased risk of leukemia, non- Hodgkin’s lymphoma (NHL) and other blood-related cancers


Obesity lawsuit against McDonald’s concludes
  • Shook Hardy & Bacon LLP
  • USA
  • March 3 2011

The parties in obesity-related litigation, brought on behalf of several teenagers against fast-food giant McDonald's Corp. in 2002, have filed a stipulation of voluntary dismissal with prejudice


Here, there, & everywhere: jurisdiction & venue in patent cases
  • Shook Hardy & Bacon LLP
  • USA
  • April 30 2016

Venue shopping can exert strong influence on patent suit success, causing litigants, courts, and legislatures to wrestle with boundaries. The Federal


Takeda acquires access to Envoy’s CNS drug pipeline and bacTRAP technology
  • Shook Hardy & Bacon LLP
  • USA
  • November 15 2012

Takeda America Holdings, Inc. has reportedly acquired Envoy Therapeutics, Inc. in a deal worth $140 million, including an up-front payment and progressdependent milestone payments


FDA issues final rule on mica-based pearlescent pigments in distilled spirits
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2015

The U.S. Food and Drug Administration (FDA) has issued a final rule allowing "the safe use of mica-based pearlescent pigments prepared from titanium


Does consumer awareness of food addiction affect eating behavior?
  • Shook Hardy & Bacon LLP
  • USA
  • April 24 2015

Raising concerns about how the media portrays the concept of food addiction, a new study questions whether endorsement of this model "may cause


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


Study questions alleged link between junk food in schools and childhood obesity
  • Shook Hardy & Bacon LLP
  • USA
  • April 20 2012

A recent study attempting “to isolate the causal effect of junk food availability on children’s food consumption and body mass index (BMI)” has concluded that access to competitive foods in schools “does not significantly increase BMI or obesity among this fifth-grade cohort despite the increased likelihood of in-school junk food purchases.”